Targeted Quantification of Phosphorylation Dynamics in the Context of EGFR-MAPK Pathway

被引:34
|
作者
Yi, Lian [1 ]
Shi, Tujin [1 ]
Gritsenko, Marina A. [1 ]
Chan, Chi-Yuet X'avia [1 ]
Fillmore, Thomas L. [2 ]
Hess, Becky M. [3 ]
Swensen, Adam C. [1 ]
Liu, Tao [1 ]
Smith, Richard D. [1 ,2 ]
Wiley, H. Steven [2 ]
Qian, Wei-Jun [1 ]
机构
[1] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA
[2] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA
[3] Pacific Northwest Natl Lab, Signatures Sci & Technol Div, Richland, WA 99352 USA
关键词
TYROSINE PHOSPHORYLATION; ENRICHMENT; REVEALS; CANCER; CELLS; PHOSPHOPROTEOMICS; PROTEOMICS; PROTEINS; KINASES; GROWTH;
D O I
10.1021/acs.analchem.8b00071
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Large-scale phosphoproteomics with coverage of over 10,000 sites of phosphorylation have now been routinely achieved with advanced mass spectrometry (MS)-based workflows. However, accurate targeted MS-based quantification of phosphorylation dynamics, an important direction for gaining quantitative understanding of signaling pathways or networks, has been much less investigated. Herein, we report an assessment of the targeted workflow in the context of signal transduction pathways, using the epidermal growth factor receptor (EGFR)-mitogen-activated protein kinase (MAPK) pathway as our model. A total of 43 phosphopeptides from the EGFR-MAPK pathway were selected for the study. The recovery and sensitivity of two commonly used enrichment methods, immobilized metal affinity chromatography (IMAC) and titanium oxide (TiO2), combined with selected reaction monitoring (SRM)-MS were evaluated. The recovery of phosphopeptides by IMAC and TiO2 enrichment was quantified to be 38 +/- 5% and 58 +/- 20%, respectively, based on internal standards. Moreover, both enrichment methods provided comparable sensitivity from 1 to 100 mu g starting peptides. Robust quantification was consistently achieved for most targeted phosphopeptides when starting with 25-100 mu g peptides. However, the numbers of quantified targets significantly dropped when peptide samples were in the 1-25 mu g range. Finally, IMAC-SRM was applied to quantify signaling dynamics of EGFR-MAPK pathway in Hs578T cells following 10 ng/mL EGF treatment. The kinetics of phosphorylation clearly revealed early and late phases of phosphorylation, even for very low abundance proteins. These results demonstrate the feasibility of robust targeted quantification of phosphorylation dynamics for specific pathways, even starting with relatively small amounts of protein.
引用
收藏
页码:5256 / 5263
页数:8
相关论文
共 50 条
  • [21] YAP in MAPK pathway targeted therapy resistance
    Flaherty, Keith T.
    Wargo, Jennifer A.
    Bivona, Trever G.
    [J]. CELL CYCLE, 2015, 14 (12) : 1765 - 1766
  • [22] Interaction of pralatrexate with the EGFR/MAPK pathway leads to synergistic activity with EGFR inhibitors
    Serova, Maria
    Bieche, Ivan
    Vidaud, Michel
    Pronk, Gijsbertus J.
    Cvitkovic, Esteban
    Faivre, Sandrine
    Raymond, Eric
    [J]. CANCER RESEARCH, 2011, 71
  • [23] Sensitive Targeted Quantification of ERK Phosphorylation Dynamics and Stoichiometry in Human Cells without Affinity Enrichment
    Shi, Tujin
    Gao, Yuqian
    Gaffrey, Matthew J.
    Nicora, Carrie D.
    Fillmore, Thomas L.
    Chrisler, William B.
    Gritsenko, Marina A.
    Wu, Chaochao
    He, Jintang
    Bloodsworth, Kent J.
    Zhao, Rui
    Camp, David G., II
    Liu, Tao
    Rodland, Karin D.
    Smith, Richard D.
    Wiley, H. Steven
    Qian, Wei-Jun
    [J]. ANALYTICAL CHEMISTRY, 2015, 87 (02) : 1103 - 1110
  • [24] SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway
    Kang, L.
    Zhang, Z. H.
    Zhao, Y.
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 14240 - 14240
  • [25] Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells
    Centuori, Sara M.
    Gomes, Cecil J.
    Trujillo, Jesse
    Borg, Jamie
    Brownlee, Joshua
    Putnam, Charles W.
    Martinez, Jesse D.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (07): : 663 - 670
  • [26] Negative Regulation of the EGFR-MAPK Cascade by Actin-MAL-Mediated Mig6/Errfi-1 Induction
    Descot, Arnaud
    Hoffmann, Reinhard
    Shaposhnikov, Dmitry
    Reschke, Markus
    Ullrich, Axel
    Posern, Guido
    [J]. MOLECULAR CELL, 2009, 35 (03) : 291 - 304
  • [27] Targeted Quantification of Phosphorylation Sites Identifies STRIPAK-Dependent Phosphorylation of the Hippo Pathway-Related Kinase SmKIN3
    Stein, Valentina
    Blank-Landeshammer, Bernhard
    Marker, Ramona
    Sickmann, Albert
    Kueck, Ulrich
    [J]. MBIO, 2021, 12 (03):
  • [28] Negative Regulation of EGFR/MAPK Pathway by Pumilio in Drosophila melanogaster
    Kim, Sung Yun
    Kim, Ji Young
    Malik, Sumira
    Son, Wonseok
    Kwon, Ki-Sun
    Kim, Changsoo
    [J]. PLOS ONE, 2012, 7 (04):
  • [29] Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
    Ma, Pengfei
    Fu, Yujie
    Chen, Minjiang
    Jing, Ying
    Wu, Jie
    Li, Ke
    Shen, Ying
    Gao, Jian-Xin
    Wang, Mengzhao
    Zhao, Xiaojing
    Zhuang, Guanglei
    [J]. THERANOSTICS, 2016, 6 (08): : 1232 - 1243
  • [30] EGFR ACTIVATION CONFERS RESISTANCE TO MAPK PATHWAY INHIBITORS IN GLIOMA
    Zhang, Jie
    Hariono, Sujatmi
    Hashizume, Rintaro
    Fan, Qiwen
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    [J]. NEURO-ONCOLOGY, 2013, 15 : 31 - 32